Add to a list

Inactive Instrument

Carmat Stock Other OTC

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: Carmat

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
10/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

05/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	6.15M 7.03M 5.68M 5.22M 9.87M 677M 10.04M 67.78M 26.63M 331M 26.4M 25.82M 1.14B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.78M 54.79M 50.28M 95.16M 6.53B 96.81M 653M 257M 3.19B 255M 249M 11.01B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
07/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
07/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
05/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
16/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
05/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+4.66%	+1.25%	-15.27%	+10.91%	121B
SMITH & NEPHEW PLC	+1.04%	+3.29%	+5.78%	-1.44%	13.07B
GLAUKOS CORPORATION	-0.92%	+0.21%	+57.76%	+98.61%	9.21B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.39%	+12.27%	-43.55%	-69.82%	4.2B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.12%	+10.06%	+14.61%	+52.41%	2.91B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-0.07%	-2.56%	-15.45%	-27.09%	1.73B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.73%	+4.88%	-4.51%	-19.41%	1.67B
ENOVIS CORPORATION	+9.69%	+11.30%	-8.09%	-56.81%	1.47B
Average	+1.95%	+3.46%	-1.09%	-1.58%	19.45B
Weighted average by Cap.	+3.85%	-1.74%	-9.20%	+12.27%

	2023	2024
Net sales	3.84M 4.39M 3.55M 3.26M 6.16M 423M 6.27M 42.32M 16.62M 207M 16.48M 16.12M 713M	7.34M 8.4M 6.79M 6.23M 11.8M 810M 12M 81M 31.82M 395M 31.55M 30.86M 1.36B
Net income	-53.87M -61.63M -49.82M -45.71M -86.52M -5.94B -88.02M -594M -233M -2.9B -231M -226M -10.01B	-51.4M -58.8M -47.53M -43.61M -82.55M -5.67B -83.98M -567M -223M -2.77B -221M -216M -9.55B
Net Debt	49.64M 56.79M 45.9M 42.12M 79.72M 5.47B 81.11M 547M 215M 2.67B 213M 209M 9.23B	53.1M 60.75M 49.11M 45.06M 85.29M 5.85B 86.77M 586M 230M 2.86B 228M 223M 9.87B

Carmat Stock Other OTC

Stocks

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile